206 related articles for article (PubMed ID: 28674244)
1. Analysis of the Mechanism of Prolonged Persistence of Drug Interaction between Terbinafine and Amitriptyline or Nortriptyline.
Mikami A; Hori S; Ohtani H; Sawada Y
Biol Pharm Bull; 2017; 40(7):1010-1020. PubMed ID: 28674244
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interaction between nortriptyline and terbinafine.
Van Der Kuy PH; Van Den Heuvel HA; Kempen RW; Vanmolkot LM
Ann Pharmacother; 2002 Nov; 36(11):1712-4. PubMed ID: 12398564
[TBL] [Abstract][Full Text] [Related]
3. Prolonged pharmacokinetic drug interaction between terbinafine and amitriptyline.
Castberg I; Helle J; Aamo TO
Ther Drug Monit; 2005 Oct; 27(5):680-2. PubMed ID: 16175144
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: mechanism of drug interaction between TCAs and phenytoin.
Shin JG; Park JY; Kim MJ; Shon JH; Yoon YR; Cha IJ; Lee SS; Oh SW; Kim SW; Flockhart DA
Drug Metab Dispos; 2002 Oct; 30(10):1102-7. PubMed ID: 12228186
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory Effects of Tricyclic Antidepressants on Human Liver Microsomal Morphine Glucuronidation: Application of IVIVE to Predict Potential Drug-Drug Interactions in Humans.
Uchaipichat V
Curr Drug Metab; 2023; 24(12):835-843. PubMed ID: 38270153
[TBL] [Abstract][Full Text] [Related]
6. Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s.
Wen B; Ma L; Zhu M
Chem Biol Interact; 2008 May; 173(1):59-67. PubMed ID: 18359012
[TBL] [Abstract][Full Text] [Related]
7. Regioselectivity and substrate concentration-dependency of involvement of the CYP2D subfamily in oxidative metabolism of amitriptyline and nortriptyline in rat liver microsomes.
Masubuchi Y; Iwasa T; Fujita S; Suzuki T; Horie T; Narimatsu S
J Pharm Pharmacol; 1996 Sep; 48(9):925-9. PubMed ID: 9036183
[TBL] [Abstract][Full Text] [Related]
8. Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics.
Wong SL; Cavanaugh J; Shi H; Awni WM; Granneman GR
Clin Pharmacol Ther; 1996 Jul; 60(1):48-53. PubMed ID: 8689811
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Modeling Analysis Demonstrates the Impact of CYP2C19 and CYP2D6 Genetic Polymorphisms on the Pharmacokinetics of Amitriptyline and Its Metabolite, Nortriptyline.
Koh A; Pak KC; Choi HY; Ryu S; Choi SE; Kim KS; Bae KS; Lim HS
J Clin Pharmacol; 2019 Apr; 59(4):532-540. PubMed ID: 30452773
[TBL] [Abstract][Full Text] [Related]
11. The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha1B-adrenoceptors.
Nojimoto FD; Mueller A; Hebeler-Barbosa F; Akinaga J; Lima V; Kiguti LR; Pupo AS
Neuropharmacology; 2010; 59(1-2):49-57. PubMed ID: 20363235
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine.
Abdel-Rahman SM; Marcucci K; Boge T; Gotschall RR; Kearns GL; Leeder JS
Drug Metab Dispos; 1999 Jul; 27(7):770-5. PubMed ID: 10383919
[TBL] [Abstract][Full Text] [Related]
13. Toxicokinetics of nortriptyline and amitriptyline: two case reports.
Franssen EJ; Kunst PW; Bet PM; Strack van Schijndel RJ; van Loenen AC; Wilhelm AJ
Ther Drug Monit; 2003 Apr; 25(2):248-51. PubMed ID: 12657923
[TBL] [Abstract][Full Text] [Related]
14. Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes.
Mellström B; von Bahr C
Drug Metab Dispos; 1981; 9(6):565-8. PubMed ID: 6120818
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent inhibition of human drug metabolizing cytochromes P450 by tricyclic antidepressants.
Polasek TM; Miners JO
Br J Clin Pharmacol; 2008 Jan; 65(1):87-97. PubMed ID: 17662092
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction between nevirapine and nortriptyline in rats: inhibition of nevirapine metabolism by nortriptyline.
Usach I; Melis V; Gandía P; Peris JE
Antimicrob Agents Chemother; 2014 Dec; 58(12):7041-8. PubMed ID: 25224004
[TBL] [Abstract][Full Text] [Related]
17. Drug interactions of amitriptyline and nortriptyline with warfarin in the rat.
Loomis CW; Racz WJ
Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):41-58. PubMed ID: 7433768
[TBL] [Abstract][Full Text] [Related]
18. Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers.
Madani S; Barilla D; Cramer J; Wang Y; Paul C
J Clin Pharmacol; 2002 Nov; 42(11):1211-8. PubMed ID: 12412819
[TBL] [Abstract][Full Text] [Related]
19. Rates of in vivo methylation of desipramine and nortriptyline.
Kurpius MP; Alexander B
Pharmacotherapy; 2006 Apr; 26(4):505-10. PubMed ID: 16553509
[TBL] [Abstract][Full Text] [Related]
20. Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine.
Hynninen VV; Olkkola KT; Bertilsson L; Kurkinen K; Neuvonen PJ; Laine K
Clin Pharmacol Ther; 2008 Feb; 83(2):342-8. PubMed ID: 17687273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
